Enabling Growth Through a Key QA Leadership Hire
How we helped Scholar Rock overcome location and expertise challenges to secure a pivotal senior hire in Clinical Quality Assurance.
Scholar Rock, a mid-sized US biotech company, faced a critical need to expand its quality department by hiring an Associate Director of Clinical Quality Assurance. After a month-long internal search, the position remained open—underscoring the challenge of finding a candidate with the right combination of GCP expertise, leadership skills, and willingness to work onsite in Cambridge, MA.

Challenges Identified
Scholar Rock needed an Associate Director of Clinical Quality Assurance with deep GCP knowledge and the confidence to lead independently. The seniority of the role, coupled with its onsite requirement, made it difficult to attract candidates willing to relocate or manage a long commute. The position was also foundational to building a broader QA team, increasing the urgency to fill it successfully.
What Was at Stake
Without securing the right leader, Scholar Rock risked delays in expanding its QA department, which could have slowed the company’s operational growth and its ability to support ongoing clinical programs.

Our Strategy and Approach
Results
We delivered the successful hire—a Director of Clinical Quality Assurance—within nine working days of receiving the brief. This key appointment gave Scholar Rock the leadership it needed to continue building out its quality department and strengthen operational efficiency.


Impact
The placement provided the structure and leadership required to scale the QA function effectively, allowing Scholar Rock to maintain its commitment to excellence in clinical quality and sustain its long-term growth.
Build Your Own Success Story
Let us help you secure the leadership talent your organization needs to grow—just as we did for Scholar Rock. Get in touch to discuss your hiring needs and start building your success story today.
Explore Similar Projects

We began working with Ablative after a major funding round, where they had their initial sights set on the launch of their clinical program within Europe and required staff across 8 sites.

With fast-tracked designation for their lead product, AveXis required highly-skilled candidates with expertise in neuroscience and orphan diseases to lead their product to commercialization.

RVAC Medicines, a biotech firm specializing in mRNA technology, was embarking on an exciting journey to launch a new R&D facility in Boston—a previously unknown territory to them.